Potentially malignant disorders of the oral and oropharyngeal mucosa; terminology, classification and present concepts of management

Oral Oncology

Volumn 45, Issue 4-5, 2009, Pages 317-323

  van der Waal, Isaäc ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Actinic cheilitis; Oral leukoplakia; Oral lichen planus; Potentially malignant oral disorders; Submucous fibrosis

Indexed keywords

CANCER CLASSIFICATION; CANCER DIAGNOSIS; CANCER GROWTH; CANCER RISK; CANCER STAGING; CANCER SURGERY; CANCER SUSCEPTIBILITY; CARCINOMA IN SITU; CHEILITIS; CYTOLOGY; DIAGNOSTIC VALUE; ERYTHROPLASIA; FAMILIAL CANCER; FOLLOW UP; HISTOPATHOLOGY; HUMAN; IMMUNE DEFICIENCY; LASER SURGERY; LEUKOPLAKIA; LICHEN PLANUS; MALIGNANT TRANSFORMATION; MOLECULAR BIOLOGY; MOUTH CANCER; MOUTH DISEASE; MOUTH MUCOSA; NOMENCLATURE; ORAL BIOPSY; OROPHARYNX; OROPHARYNX CANCER; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SQUAMOUS CELL CARCINOMA; VERRUCOUS CARCINOMA;

CARCINOMA, SQUAMOUS CELL; CELL TRANSFORMATION, NEOPLASTIC; CHEILITIS; ERYTHROPLASIA; HUMANS; LEUKOPLAKIA, ORAL; LICHEN PLANUS, ORAL; MOUTH MUCOSA; MOUTH NEOPLASMS; ORAL SUBMUCOUS FIBROSIS; PRACTICE GUIDELINES AS TOPIC; PRECANCEROUS CONDITIONS; TERMINOLOGY AS TOPIC; WORLD HEALTH ORGANIZATION;

EID: 67349286178     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2008.05.016     Document Type: Review

References (89)

1. Warnakulasuriya S., Johnson N.W., and van der Waal I. Nomenclature and classification of potentially malignant disorders of the oral mucosa. J Oral Pathol Med 36 (2007) 575-580
2. Petti S. Pooled estimate of world leukoplakia prevalence: a systematic review. Oral Oncol 39 (2003) 770-780
3. Baric J.M., Alman J.E., Feldman R.S., and Chauncey H.H. Influence of cigarette, pipe, and cigar smoking, removable partial dentures, and age on oral leukoplakia. Oral Surg Oral Med Oral Pathol 54 (1982) 424-429
4. Maserejian N.N., Joshipura K.J., Rosner B.A., Giovannucci E., and Zavras A.I. Prospective study of alcohol consumption and risk of oral premalignant lesions in men. Cancer Epidemiol Biomarkers Prev 15 (2006) 774-781
5. Bagan J.V., Jimenez Y., Murillo J., et al. Lack of association between proliferative verrucous leukoplakia and human papillomavirus infection. J Oral Maxillofac Surg 65 (2007) 46-49
6. Campisi G., Giovannelli L., Arico P., et al. HPV DNA in clinically different variants of oral leukoplakia and lichen planus. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 98 (2004) 705-711
7. Fornatora M., Jones A.C., Kerpel S., and Freedman P. Human papillomavirus-associated oral epithelial dysplasia (koilocytic dysplasia). An entity of unknown biologic potential. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 82 (1996) 47-56
8. Hansen L.S., Olson J.A., and Silverman Jr. S. Proliferative verrucous leukoplakia. A long-term study of thirty patients. Oral Surg Oral Med Oral Pathol 60 (1985) 285-298
9. Cabay R.J., Morton T.H., and Epstein J.B. Proliferative verrucous leukoplakia and its progression to oral carcinoma: a review of the literature. J Oral Pathol Med 36 (2007) 255-261
10. van der Waal I, Reichart PA. Oral proliferative verrucous leukoplakia revisited. Oral Oncol, in press, doi:10.1016/j.oraloncology.2007.09.010.
11. Barnes L, Eveson JW, Reichart PA, Sidransky D. World Health Organization classification of tumours. Pathology and genetics. Head and neck tumours. World Health Organization; 2005.
12. Abbey L.M., Kaugars G.E., Gunsolley J.C., et al. Intraexaminer and interexaminer reliability in the diagnosis of oral epithelial dysplasia. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 80 (1995) 188-191
13. Karabulut A., Reibel J., Therkildsen M.H., Praetorius F., Nielsen H.W., and Dabelsteen E. Observer variability in the histologic assessment of oral premalignant lesions. J Oral Pathol Med 24 (1995) 198-200
14. Kujan O., Khattab A., Oliver R.J., Roberts S.A., Thakker N., and Sloan P. Why oral histopathology suffers inter-observer variability on grading oral epithelial dysplasia: an attempt to understand the sources of variation. Oral Oncol 43 (2007) 224-231
15. Kujan O., Oliver R.J., Khattab A., Roberts S.A., Thakker N., and Sloan P. Evaluation of a new binary system of grading oral epithelial dysplasia for prediction of malignant transformation. Oral Oncol 42 (2006) 987-993
16. Chattopadhyay A., and Ray J.G. AgNOR cut-point to distinguish mild and moderate epithelial dysplasia. J Oral Pathol Med 37 (2008) 78-82
17. Murrah V.A., and Batsakis J.G. Proliferative verrucous leukoplakia and verrucous hyperplasia. Ann Otol Rhinol Laryngol 103 (1994) 660-663
18. Shear M., and Pindborg J.J. Verrucous hyperplasia of the oral mucosa. Cancer 46 (1980) 1855-1862
19. Gupta P.C., Mehta F.S., Daftary D.K., et al. Incidence rates of oral cancer and natural history of oral precancerous lesions in a 10-year follow-up study of Indian villagers. Community Dent Oral Epidemiol 8 (1980) 283-333
20. Holmstrup P., Vedtofte P., Reibel J., and Stoltze K. Long-term treatment outcome of oral premalignant lesions. Oral Oncol 42 (2006) 461-474
21. Schwarz S., Bier J., and Driemel O. Losses of 3p14 and 9p21 as shown by fluorescence in situ hybridization are early events in tumorigenesis of oral squamous cell carcinoma and already occur in simple keratosis. Cytom A 73A (2008) 305-311
22. Field E.A., Field J.K., and Martin M.V. Does Candida have a role in oral epithelial neoplasia?. J Med Vet Mycol 27 (1989) 277-294
23. Brennan M., Migliorati C.A., Lockhart P.B., et al. Management of oral epithelial dysplasia: a review. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 103 Suppl. 1 (2007) S19
24. Kawaguchi H., El-Naggar A.K., Papadimitrakopoulou V., et al. Podoplanin: a novel marker for oral cancer risk in patients with oral premalignancy. J Clin Oncol 26 (2008) 354-360
25. Vora H.H., Trivedi T.I., Shukla S.N., Shah N.G., Goswami J.V., and Shah P.M. p53 expression in leukoplakia and carcinoma of the tongue. Int J Biol Markers 21 (2006) 74-80
26. Johnstone S., and Logan R.M. Expression of vascular endothelial growth factor (VEGF) in normal oral mucosa, oral dysplasia and oral squamous cell carcinoma. Int J Oral Maxillofac Surg 36 (2007) 263-266
27. Luo C.W., Roan C.H., and Liu C.J. Human papillomaviruses in oral squamous cell carcinoma and pre-cancerous lesions detected by PCR-based gene-chip array. Int J Oral Maxillofac Surg 36 (2007) 153-158
28. Kovesi G., and Szende B. Prognostic value of cyclin D1, p27, and p63 in oral leukoplakia. J Oral Pathol Med 35 (2006) 274-277
29. Gires O., Mack B., Rauch J., and Matthias C. CK8 correlates with malignancy in leukoplakia and carcinomas of the head and neck. Biochem Biophys Res Commun 343 (2006) 252-259
30. Furrer V.E., Benitez M.B., Furnes M., Lanfranchi H.E., and Modesti N.M. Biopsy vs. superficial scraping: detection of human papillomavirus 6, 11, 16, and 18 in potentially malignant and malignant oral lesions. J Oral Pathol Med 35 (2006) 338-344
31. Bremmer J.F., Braakhuis B.J.M., Ruijter-Schippers H.J., et al. A noninvasive genetic screening test to detect oral precancerous lesions. Laboratory Invest 85 (2005) 1481-1488
32. Smith E.M., Ritchie J.M., Summersgill K.F., et al. Human papillomavirus in oral exfoliated cells and risk of head and neck cancer. J Nat Cancer Inst 96 (2004) 449-455
33. Brailo V., Vucicevic-Boras V., Cekic-Arambasin A., Alajbeg I.Z., Milenovic A., and Lukac J. The significance of salivary interleukin 6 and tumor necrosis factor alpha in patients with oral leukoplakia. Oral Oncol 42 (2006) 370-373
34. Rhodus N.L., Ho V., Miller C.S., Myers S., and Ondrey F. NF-kappaB dependent cytokine levels in saliva of patients with oral preneoplastic lesions and oral squamous cell carcinoma. Cancer Detect Prev 29 (2005) 42-45
35. Poate T.W.J., and Warnakulasuriya S. Effective management of smoking in an oral dysplasia clinic in London. Oral Dis 12 (2006) 22-26
36. Thomson P.J., and Hamadah O. Cancerisation within the oral cavity: the use of 'field mapping biopsies' in clinical management. Oral Oncol 43 (2007) 20-26
37. Holmstrup P., Vedtofte P., Reibel J., and Stoltze K. Oral premalignant lesions: Is a biopsy reliable?. J Oral Pathol Med 36 (2007) 262-266
38. Lee J.J., Hung H.C., Cheng S.J., et al. Factors associated with underdiagnosis from incisional biopsy of oral leukoplakic lesions. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 104 (2007) 217-225
39. Kujan O., Desai M., Sargent A., Bailey A., Turner A., and Sloan P. Potential applications of oral brush cytology with liquid-based technology: results from a cohort of normal oral mucosa. Oral Oncol 42 (2006) 810-818
40. Greenberg M.S. The "brush" controversy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 93 (2002) 217-218
41. Scheifele C., Schmidt-Westhausen A.M., Dietrich T., and Reichart P.A. The sensitivity and specificity of the OralCDx technique: evaluation of 103 cases. Oral Oncol 40 (2004) 824-828
42. Gandolfo S., Pentenero M., Broccoletti R., Pagano M., Carrozzo M., and Scully C. Toluidine blue uptake in potentially malignant oral lesions in vivo: clinical and histological assessment. Oral Oncol 42 (2006) 89-95
43. Epstein J.B., Zhang L., Poh C., Nakamura H., Berean K., and Rosin M. Increased allelic loss in toluidine blue-positive oral premalignant lesions. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 95 (2003) 45-50
44. Zhang L., Williams M., Poh C.F., et al. Toluidine blue staining identifies high-risk primary oral premalignant lesions with poor outcome. Cancer Res 65 (2005) 8017-8021
45. Epstein J.B., Sciubba J., Silverman S., and Sroussi H.Y. Utility of toluidine blue in oral premalignant lesions and squamous cell carcinoma: continuing research and implications for clinical practice. Head Neck 29 (2007) 948-958
46. Sharwani A., Jerjes W., Salih V., et al. Assessment of oral premalignancy using elastic scattering spectroscopy. Oral Oncol 42 (2006) 343-349
47. Poh C.F., Zhang L., Anderson D.W., et al. Fluorescence visualization detection of field alterations in tumor margins of oral cancer patients. Clin Cancer Res 12 (2006) 6716-6722
48. Westra W.H., and Sidransky D. Fluorescence visualization in oral neoplasia: shedding light on an old problem. Clin Cancer Res 12 (2006) 6594-6597
49. Epstein J.B., Gorsky M., Lonky S., Silverman Jr. S., Epstein J.D., and Bride M. The efficacy of oral luminoscopy (ViziLite) in visualizing oral mucosal lesions. Spec Care Dentist 26 (2006) 171-174
50. Lodi G., Sardella A., Bez C., Demarosi F., and Carrassi A. Interventions for treating oral leukoplakia (Review). Cochrane Database Syst Rev 4 (2006) CD001829
51. Tradati N., Grigolat R., Calabrese L., et al. Oral leukoplakias: To treat or not?. Oral Oncol 33 (1997) 317-321
52. 2 laser in the treatment of oral white patches: outcomes and factors affecting recurrence. Int J Oral Maxillofac Surg 34 (2005) 396-400
53. 2 laser surgery in patients with oral leukoplakia: a 25 year follow up. Oral Oncol 41 (2005) 31-37
54. Chiesa F., Tradati N., Grigolato R., et al. Randomized trial of fenretinide (4-HPR) to prevent recurrences, new localizations and carcinomas in patients operated on for oral leukoplakia: long-term results. Int J Cancer 115 (2005) 625-629
55. Mulshine J.L., Atkinson J.C., Greer R.O., et al. Randomized, double-blind, placebo-controlled phase IIB trial of the cyclooxygenase inhibitor ketorolac as an oral rinse in oropharyngeal leukoplakia. Clin Cancer Res 10 (2004) 1565-1573
56. Sood S., Shiff S.J., Yang C.S., and Chen X. Selection of topically applied non-steroidal anti-inflammatory drugs for oral cancer chemoprevention. Oral Oncol 41 (2005) 562-567
57. Rudin C.M., Cohen E.E.W., Papadimitrakopoulou V.A., et al. An attenuated adenovirus, ONYX-015, as mouthwash therapy for premalignant oral dysplasia. J Clin Oncol 21 (2003) 4546-4552
58. Gaballah K., Hills A., Curiel D., Hallden G., Harrison P., and Partridge M. Lysis of dysplastic but not normal oral keratinocytes and tissue-engineered epithelia with conditionally replicating adenoviruses. Cancer Res 67 (2007) 7284-7294
59. Kvaal S.I., and Warloe T. Photodynamic treatment of oral lesions. J Environ Pathol Toxicol Oncol 26 (2007) 127-133
60. Ishii J., Fujita K., and Komori T. Laser surgery as a treatment for oral leukoplakia. Oral Oncol 39 (2003) 759-769
61. Vedtofte P., Holmstrup P., Hjorting-Hansen E., and Pindborg J.J. Surgical treatment of premalignant lesions of the oral mucosa. Int J Oral Maxillofac Surg 16 (1987) 656-664
62. van der Waal I., and Axell T. Oral leukoplakia: a proposal for uniform reporting. Oral Oncol 38 (2002) 521-526
63. Miller A.B., Hoogstraten B., Staquet M., and Winkler A. Reporting results of cancer treatment. Cancer 47 (1981) 207-214
64. Pindborg J.J., Reichart P.A., Smith C.J., and van der Waal I. Histological typing of cancer and precancer of the oral mucosa. International histological classification of tumours (1997), World Health Organization
65. Reichart P.A., and Philipsen H.P. Oral erythroplakia. A review. Oral Oncol 41 (2005) 551-561
66. Shafer W.G., and Waldron C.A. Erythroplakia of the oral cavity. Cancer 36 (1975) 1021-1028
67. Hsue S.S., Wang W.C., Chen C.H., Lin C.C., Chen Y.K., and Lin L.M. Malignant transformation in 1458 patients with potentially malignant oral mucosal disorders: a follow-up study based in a Taiwanese hospital. J Oral Pathol Med 36 (2007) 25-29
68. Mattsson U., Jontell M., and Holmstrup P. Oral lichen planus and malignant transformation: Is a recall of patients justified?. Crit Rev Oral Biol Med 13 (2002) 390-396
69. Roosaar A., Yin L., Sandborgh-Englund G., Nyren O., and Axell T. On the natural course of oral lichen lesions in a Swedish population-based sample. J Oral Pathol Med 35 (2006) 257-261
70. van der Meij E.H., Mast H., and van der Waal I. The possible premalignant character of oral lichen planus and oral lichenoid lesions: a prospective five-year follow-up study of 192 patients. Oral Oncol 43 (2007) 742-748
71. Gandolfo S., Richiardi L., Carrozzo M., et al. Risk of oral squamous cell carcinoma in 402 patients with oral lichen planus: a follow-up study in an Italian population. Oral Oncol 40 (2004) 77-83
72. van der Meij E.H., and van der Waal I. Lack of clinicopathologic correlation in the diagnosis of oral lichen planus based on the presently available diagnostic criteria and suggestions for modifications. J Oral Pathol Med 32 (2003) 507-512
73. Larsson A., and Warfvinge G. Oral lichenoid contact reactions may occasionally transform into malignancy. Eur J Cancer Prev 14 (2005) 525-529
74. Krutchkoff D.J., and Eisenberg E. Lichenoid dysplasia: a distinct histopathologic entity. Oral Surg Oral Med Oral Pathol 60 (1985) 308-315
75. Eisenberg E. Clinical controversies in oral and maxillofacial surgery. Part one. Oral lichen planus: a benign lesion. J Oral Maxillofac Surg 58 (2000) 1278-1285
76. Al-Hashimi I., Schifter M., Lockhart P.B., et al. Oral lichen planus and oral lichenoid lesions: diagnostic and therapeutic considerations. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 103 Suppl. 1 (2007) S25
77. Eisen D. The clinical features, malignant potential, and systemic associations of oral lichen planus: a study of 723 patients. J Am Acad Dermatol 46 (2002) 207-214
78. Xue J.L., Fan M.W., Wang S.Z., Chen X.M., Li Y., and Wang L. A clinical study of 674 patients with oral lichen planus in China. J Oral Pathol Med 34 (2005) 467-472
79. Mignogna M.D., Fedele S., and Lo Russo L. Dysplasia/neoplasia surveillance in oral lichen planus patients: a description of clinical criteria adopted at a single centre and their impact on prognosis. Oral Oncol 42 (2006) 819-824
80. Tilakaratne W.M., Klinikowski M.F., Saku T., Peters T.J., and Warnakulasuriya S. Oral submucous fibrosis: review on aetiology and pathogenesis. Oral Oncol 42 (2006) 561-568
81. Murti P.R., Bhonsle R.B., Pindborg J.J., Daftary D.K., Gupta P.C., and Mehta F.S. Malignant transformation rate in oral submucous fibrosis over a 17-year period. Community Dent Oral Epidemiol 13 (1985) 340-341
82. Satorres N.M., Gargallo A.J., and Gay E.C. Surgical management of actinic cheilitis. Med Oral 6 (2001) 205-217
83. Berking C., Herzinger T., Flaig M.J., Brenner M., Borelli C., and Degitz K. The efficacy of photodynamic therapy in actinic cheilitis of the lower lip: a prospective study of 15 patients. Dermatol Surg 33 (2007) 825-830
84. Prime S.S., Thakker N.S., Pring M., Guest P.G., and Paterson I.C. A review of inherited cancer syndromes and their relevance to oral squamous cell carcinoma. Oral Oncol 37 (2001) 1-16
85. Visscher de J.G.A.M., Bouwes Bavinck J.N., and van der Waal I. Squamous cell carcinoma of the lower lip in renal-transplant recipients. Report of six cases. Int J Oral Maxillofac Surg 26 (1997) 120-123
86. Scheifele C., Reichart P.A., Hippler-Benscheidt M., Neuhaus P., and Neuhaus R. Incidence of oral, pharyngeal, and laryngeal squamous cell carcinomas among 1515 patiens after liver transplantation. Oral Oncol 41 (2005) 670-676
87. Hernandez G., Arriba L., Jimenez C., et al. Rapid progression from oral leukoplakia to carcinoma in an immunosuppressed liver transplant recipient. Oral Oncol 39 (2003) 87-90
88. Demopoulos B.P., Vamvakas E., Ehrlich J.E., and Demopoulos R. Non-acquired immunodeficiency syndrome-defining malignancies in patients infected with human immunodeficiency virus. Arch Pathol Lab Med 127 (2003) 589-592
89. Szeto C.H., Shek T.W., Lie A.K., Au W.Y., Yuen A.P., and Kwong Y.L. Squamous cell carcinoma of the tongue complicating chronic oral mucosal graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Am J Hematol 77 (2004) 200-202